Abnormal PT/PTT Analyzer
Order Name
PT PTT AN
Test Number: 1507500
Revision Date 10/08/2024
Test Number: 1507500
Revision Date 10/08/2024
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Abnormal PT/PTT Analyzer
|
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 37.5 mL | See Instructions | See Instructions | See Instructions |
| Instructions | Please list the patient's anticoagulant on the "Coagulopathy Questionnaire Form" and submit with specimen or fax to 918-744-2897. Please collect: Seven 2.7mL Sodium Citrate 3.2% (Blue Top) tubes and One 5mL Clot Activator SST - send refrigerated. Each 2.7mL Sodium Citrate 3.2% (Blue Top) tube must be filled to the proper level, no hemolysis. Improperly filled tubes can give erroneous results. Whole blood must be transported to lab immediately. If testing cannot be started within 4 hours of collection the specimen must be double spun then 1.5mL plasma aliquot from each tube into individual plastic aliquot tubes and freeze. Do not pool aliquots together! Coagulopathy Questionnaire Form Double Spin Procedure |
|||
| GENERAL INFORMATION | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Testing Schedule | Mon, Thr Day Shift | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Expected TAT | 2-4 Days | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clinical Use | This analyzer is designed to evaluate patients with an unexplained prolonged PT or PTT in whom there is no clinical history or strong clinical suspicion of either bleeding or thrombolytic tendency. A pathologist interpretation and patient focused report with summation of test results will be issued with each order. Not recommended when patients are taking Pradaxa®, Xarelto® and Apixaban® See More Information. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CPT Code(s) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lab Section | Coagulation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||